Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Gini, Guido  [Clear All Filters]
Journal Article
Pagani C, Rusconi C, Pria ADalla, Ravano E, Schommers P, Bastos-Oreiro M, Verga L, Gini G, Spina M, Arcaini L, et al. Do MYC rearrangements Matter in HIV-Associated Large B Cell Lymphomas? "EUROMYC" Study (a European retrospective study). Blood Adv. 2024.
Guerra L, Chauvie S, Fallanca F, Bergesio F, Marcheselli L, Durmo R, Peano S, Franceschetto A, Monaco L, Barbieri E, et al. End of induction [F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. Eur J Nucl Med Mol Imaging. 2024.
Gini G, Annibali O, Lupasco D, Bocci C, Tomarchio V, Sampaolo M, Trappolini S, Tafuri MAntonietta, Cacciagiù S, Ciccarone M, et al. Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin's and Non-Hodgkin Lymphoma. Chemotherapy. 2019:1-6.
Stathis A, Pirosa MCristina, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FGaia, Merli F, Guieze R, et al. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024.
Nizzoli ME, Manni M, Ghiggi C, Pulsoni A, Musuraca G, Merli M, Califano C, Bari A, Massaia M, Conconi A, et al. Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. Hematol Oncol. 2023.
Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, Troiani E, Montanari M, Scortechini I, Offidani M, et al. Mobilization-Driven Post-Consolidation Therapy in 55 Elderly Aml Patients: Feasibility and Efficacy of Asct Vs Low Dose Gemtuzumab-Ozogamicin. Biol Blood Marrow Transplant. 2014.